Cervical Spondylosis Treatment Market, By Type of Treatment (Medications (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Muscle relaxants, Antidepressants and Others) and Surgery), By Route of Administration (Oral, Injection, Topical, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Nov 2023

Code : CMI5710

Pages :165

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Cervical Spondylosis Treatment Market Regional Insights

In 2023, North America dominated the cervical spondylosis treatment market in terms of revenue share, followed by Europe and Asia Pacific. The growth in the North America region is attributed to factors such as the high prevalence of cervical spondylosis, the availability of advanced healthcare infrastructure, and the presence of key market players. It is estimated to hold around 36.7% of the global market share. For instance, according to the StatPearls journal, in May 2023, cervical spondylosis was considered a natural process of aging with a 95% prevalence by the age of 65 years in the U.S. Most people remain asymptomatic but can suffer from axial neck pain, as well as with cervical radiculopathy and/or cervical myelopathy.
Europe is also a significant market for cervical spondylosis treatment, owing to the high prevalence of cervical spondylosis in the region and the availability of advanced healthcare infrastructure. The growing geriatric population in the region is also driving the demand for cervical spondylosis treatment. Europe is estimated to hold approximately 30.7% of the global market share.
Asia Pacific is expected to witness significant growth in the cervical spondylosis treatment market during the forecast period owing to factors such as the increasing prevalence of cervical spondylosis, the growing geriatric population, and the development of healthcare infrastructure in emerging economies. The market in the Asia Pacific region is estimated to capture around 25.2% of the global market share.

Figure 1. Global Cervical Spondylosis Treatment Market Share (%), By Region, 2023

Geographies covered

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa